Sitemap

Medizin

06/2004 Pitfalls and drawbacks in screening of congenital disorders of glycosylation
06/2004 Activity of eosinophils and immunoglobulin E concentration in the peritoneal fluid of women with endometriosis
06/2004 Rapid generation of detailed loss of heterozygosity profiles for routine diagnosis of gliomas
06/2004 Presence of secretory group IIa and V phospholipase A2 and cytosolic group IV? phospholipase A2 in chondrocytes from patients with rheumatoid arthritis
06/2004 Neurokinin B levels in maternal circulation during early pregnancy
06/2004 Cl- regulates cryoglobulin structure: a new hypothesis for the physiopathological mechanism of temperature non-dependent cryoprecipitation
06/2004 Urine labeling with orally applied marker substances in drug substitution therapy
06/2004 Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure
06/2004 Clinical utility of serum holotranscobalamin as a marker of cobalamin status in elderly patients with neuropsychiatric symptoms
06/2004 Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls
06/2004 Low S-adenosylmethionine concentrations found in patients with severe inflammatory bowel disease
06/2004 Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3)
06/2004 The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization
06/2004 First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay – Lp(a) SRM 2B
06/2004 Anwendungsgebiete der Massenspektrometrie in der Klinischen Chemie und Laboratoriumsmedizin / Application of mass spectrometry in clinical chemistry and laboratory medicine
06/2004 Anwendung der HPLC-Tandem-Massenspektrometrie in der klinischen Chemie / The use of HPLC-tandem mass spectrometry in clinical chemistry
06/2004 Gesamt-Genom-Microarray-Analyse und Target-Validierung mittels qPCR / Whole genome microarray analysis and target validation by using qPCR
06/2004 Genexpressionsanalysen bei akuten Leukämien: Diagnostik der Zukunft? / Gene expression profiling in acute leukemia: diagnostics of the future?
06/2004 DNA methylation analysis: a promising diagnostic tool / DNA-Methylierungs-Analyse: ein vielversprechendes diagnostisches Werkzeug
06/2004 Patientennahe Laboratoriumsdiagnostik (Point-of-Care-Testing): Empfehlungen zum Einsatz von unterschiedlichem Probenmaterial für die Diagnostik des Diabetes mellitus / Bedside testing in laboratory diagnostics (point-of-care testing): recommendations for
06/2004 The history, advantages and limitations of point-of-care testing for blood glucose / Geschichte, Vorteile und Grenzen des Point-of-Care-Testing im Bereich der Blutzuckerkontrolle
06/2004 Qualitätssichernde Maßnahmen im Rahmen des Point-of-Care-Testing (POCT) / Strategies for quality assurance in point-of-care testing
06/2004 Qualitätssicherung der patientennahen Sofortdiagnostik (Point-of-Care-Testing) im Krankenhaus: Muster für eine hausinterne Richtlinie / Quality assurance in bedside testing at the hospital: sample guidelines for internal use
06/2004 Online-Qualitätssicherung patientennaher Sofortdiagnostik (Point-of-Care-Testing) unter Nutzung des Kommunikations-Systems des Krankenhauses / Online quality assurance of point-of-care testing by using the hospital information system
06/2004 Das pränatale/frühkindliche Immunsystem und Allergie – Ergebnisse humaner und tierexperimenteller Studien / Prenatal and early postnatal immune system and allergy – outcomes of human and animal studies
06/2004 The laboratory responsibility in stopping the allergic march / Die Rolle des Labors beim Unterbrechen des allergischen Marsches
06/2004 Topical immunomodulators in the treatment of atopic dermatitis / Topische Immunmodulatoren bei der Behandlung der atopischen Dermatitis
06/2004 Prognostic value of soluble interleukin-2 receptor plasma levels in non-responders with chronic hepatitis C treated with pegylated interferon alpha 2b and ribavirin / Der prognostische Wert von Plasmaspiegeln des löslichen Interleukin-2-Rezeptors in mit
07/2004 Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin
07/2004 The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells
07/2004 Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cells
07/2004 Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization
07/2004 High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII
07/2004 Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide
07/2004 Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels
07/2004 The risk of bleeding complications in patients with cytochrome P450 CYP2C92 or CYP2C93 alleles on acenocoumarol or phenprocoumon
07/2004 In vitro studies, pharmacokinetic studies and clinical use of a high purity double virus inactivated FVIII/VWF concentrate (Immunate) in the treatment of von Willebrand disease
07/2004 Mutation in the leucine-rich repeat C-flanking region of platelet glycoprotein Ib impairs assembly of von Willebrand factor receptor
07/2004 Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance
07/2004 Increased platelet activation in young Zucker rats with impaired glucose tolerance is improved by acarbose
07/2004 Apoptotic-like mitochondrial events associated to phosphatidylserine exposure in blood platelets induced by local anaesthetics
07/2004 ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets
07/2004 Formation of tissue factor-bearing leukocytes during and after cardiopulmonary bypass
07/2004 Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases
07/2004 P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro
07/2004 Manganese-induced integrin affinity maturation promotes recruitment of V3 integrin to focal adhesions in endothelial cells: evidence for a role of phosphatidylinositol 3-kinase and Src
07/2004 Structural changes in cerebral arteries following nitric oxide deprivation: a comparison between normotensive and hypertensive rats
07/2004 Proteasome inhibitor prevents experimental arterial thrombosis in renovascular hypertensive rats
07/2004 Coagulation activation in young survivors of myocardial infarction (MI) a population-based case-control study
07/2004 Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma
07/2004 Antithrombotic effects of saratin on human atherosclerotic plaques
07/2004 Longitudinal analysis of perfusion lung scintigrams of patients with unoperated chronic thromboembolic pulmonary hypertension
07/2004 The evolution of the reference value concept
07/2004 Normality: the unreachable star?
07/2004 Selecting clinically relevant populations for reference intervals
07/2004 The IFCC recommendation on estimation of reference intervals. The RefVal Program
07/2004 Graphical interpretation of confidence curves in rankit plots
07/2004 Partitioning biochemical reference data into subgroups: comparison of existing methods
07/2004 Parametric methods for estimating covariate-dependent reference limits
07/2004 Reference regions of two or more dimensions
07/2004 Should we maintain the 95 percent reference intervals in the era of wellness testing? A concept paper
07/2004 Clinical interpretation of reference intervals and reference limits. A plea for assay harmonization
07/2004 Inherent biological variation and reference values
07/2004 Intraindividual reference values
07/2004 Guideline for the production of multicentre physiological reference values using the same measurement system. A proposal of the Catalan Association for Clinical Laboratory Sciences
07/2004 Proposal for guidelines to establish common biological reference intervals in large geographical areas for biochemical quantities measured frequently in serum and plasma
07/2004 Reference intervals for plasma proteins: similarities and differences between adult Caucasian and Asian Indian males in Yorkshire, UK
07/2004 Diagnostic and epidemiological implications of regional differences in serum concentrations of proteins observed in six Asian cities
07/2004 Study of reference values and biological variation: a necessity and a model for Preventive Medicine Centers
07/2004 Creation of a low-risk reference group and reference interval of fasting venous plasma glucose
Zurück zur Übersicht

Sitemap

Fachbereiche